Histone deacetylase inhibitors: clinical implications for hematological malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Histone deacetylase inhibitors: clinical implications for hematological malignancies ; volume:1 ; number:1-2 ; day:28 ; month:7 ; year:2010 ; pages:25-44 ; date:9.2010
Clinical epigenetics ; 1, Heft 1-2 (28.7.2010), 25-44, 9.2010
- Creator
-
Tambaro, Francesco Paolo
- Contributor
-
Dell’Aversana, Carmela
Carafa, Vincenzo
Nebbioso, Angela
Radic, Branka
Ferrara, Felicetto
Altucci, Lucia
SpringerLink (Online service)
- DOI
-
10.1007/s13148-010-0006-2
- URN
-
urn:nbn:de:1111-2016072633386
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tambaro, Francesco Paolo
- Dell’Aversana, Carmela
- Carafa, Vincenzo
- Nebbioso, Angela
- Radic, Branka
- Ferrara, Felicetto
- Altucci, Lucia
- SpringerLink (Online service)
Other Objects (12)
Checkpoint inhibitors in hematological malignancies
Development of class IIa histone deacetylase inhibitors
Syk inhibitors in clinical development for hematological malignancies
Nanomicelles potentiate histone deacetylase inhibitor efficacy in vitro
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Selective inhibitors of nuclear export (SINE) in hematological malignancies
High throughput screening identifies modulators of histone deacetylase inhibitors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Checkpoint inhibitors in hematological malignancies
Development of class IIa histone deacetylase inhibitors
Syk inhibitors in clinical development for hematological malignancies
Nanomicelles potentiate histone deacetylase inhibitor efficacy in vitro
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Selective inhibitors of nuclear export (SINE) in hematological malignancies
High throughput screening identifies modulators of histone deacetylase inhibitors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
SELECTIVE INHIBITORS AND TARGETED DEGRADERS OF HISTONE DEACETYLASE 10
Checkpoint inhibitors in hematological malignancies
Development of class IIa histone deacetylase inhibitors
Syk inhibitors in clinical development for hematological malignancies
Nanomicelles potentiate histone deacetylase inhibitor efficacy in vitro
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Selective inhibitors of nuclear export (SINE) in hematological malignancies
High throughput screening identifies modulators of histone deacetylase inhibitors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
Histone deacetylase inhibitor attenuates experimental fungal keratitis in mice
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins